Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Dimopoulos MA"'
Autor:
Benboubker, L, Dimopoulos, Ma, Dispenzieri, A, Catalano, J, Belch, Ar, Cavo, M., Pinto, A., Weisel, Katja, Ludwig, Heinz, Bahlis, N. Et Al., Schots, Henri
BACKGROUND: The combination melphalan-prednisone-thalidomide (MPT) is considered a standard therapy for patients with myeloma who are ineligible for stem-cell transplantation. However, emerging data on the use of lenalidomide and low-dose dexamethaso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3848::708cc1e6891e4dc72c247290cd0b9f71
https://biblio.vub.ac.be/vubir/lenalidomide-and-dexamethasone-in-transplantineligible-patients-with-myeloma(fc6783ec-fb9c-4e0e-9780-cb5c89e10354).html
https://biblio.vub.ac.be/vubir/lenalidomide-and-dexamethasone-in-transplantineligible-patients-with-myeloma(fc6783ec-fb9c-4e0e-9780-cb5c89e10354).html